inclisiran
CHEBI:CHEBI_176399
Definition
Inclisiran is a long-acting, synthetic small interfering RNA (siRNA) directed against PCSK9. It is indicated for the treatment of primary hypercholesterolemia (familial and non-familial) or mixed dyslipidemia in adults.
Alternative Names
- ALN-60212
- ALN-PCSsc
- inclisiran
- inclisiranum
- Leqvio
Treatment Applications
-
familial partial lipodystrophy type 4View Disease →
DOID:0070205
-
Leber congenital amaurosis 15View Disease →
DOID:0110189
-
primary ciliary dyskinesia 20View Disease →
DOID:0110625
Drug Classification
-
processed material
-
organic molecular entityView Class →
CHEBI:50860
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- DRON_00010000
- 2588243
- oboInOwl#hasDbXref
- Wikipedia:Inclisiran
- core#notation
- CHEBI:176399
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- oboInOwl#hasOBONamespace
- chebi_ontology
- DRON_00010000
- 2588243
- oboInOwl#hasDbXref
- Wikipedia:Inclisiran
- oboInOwl#id
- CHEBI:176399
- core#notation
- CHEBI:176399
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#2_STAR
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- rdf-schema#range
- https://w3id.org/def/predibionto#has_drug_104979
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_side_effect9142
- owl#annotatedSource
- t137850
- owl#someValuesFrom
- t3875672